• Profile
Close

Discontinuation of chronic opiate therapy after successful spinal cord stimulation is highly dependent upon the daily opioid dose

Pain Practice Aug 16, 2019

Simopoulos T, et al. - Researchers conducted a retrospective, single academic center study to determine if any of the factors noted on a standard clinical history of a patient considered for spinal cord stimulation (SCS) would be correlated with decrease or cessation of opioids following implantation. Among 214 patients who met criteria for analysis (median age of 50 years), the majority were having the diagnoses of failed back surgery syndrome and complex regional pain syndrome. Complete cessation of opioid use was identified to be only associated with a median dose of 30 mg of morphine per day, which was observed in 15% of individuals who used opioids preoperatively. Outcomes suggest that the daily dose highly influence the elimination of opioid dependence following initiation of SCS therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay